NASDAQ: NNNN
Anbio Biotechnology Stock Ownership - Who owns Anbio Biotechnology?

Insider buying vs selling

Have Anbio Biotechnology insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNNN insiders and whales buy or sell their stock.

NNNN Shareholders

What type of owners hold Anbio Biotechnology stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Geode Capital Management LLC0.01%17,130$746.35kInstitution
Ubs Group Ag0.01%10,695$465.98kInstitution
Bnp Paribas Financial Markets0.00%1,261$54.94kInstitution
Morgan Stanley0.00%400$17.43kInstitution
Wells Fargo Company0.00%100$4.36kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

NNNN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNNN0.02%0.00%
LEGN22.93%0.00%
CYTK90.09%9.91%Net SellingNet Selling
AXSM70.64%29.36%Net SellingNet Selling
RYTM87.82%12.18%Net SellingNet Buying

Anbio Biotechnology Stock Ownership FAQ

Who owns Anbio Biotechnology?

Anbio Biotechnology (NASDAQ: NNNN) is owned by 0.02% institutional shareholders, 0.00% Anbio Biotechnology insiders, and 99.98% retail investors. Geode Capital Management LLC is the largest individual Anbio Biotechnology shareholder, owning 17,130.00 shares representing 0.01% of the company. Geode Capital Management LLC's Anbio Biotechnology shares are currently valued at $739.67k.

If you're new to stock investing, here's how to buy Anbio Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.